| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -264,076 | -205,532 | -45,389 | -555,692 |
| Depreciation and amortization | 436,558 | 298,717 | 150,969 | 514,821 |
| Other amortization | 35,487 | 23,901 | 11,641 | 35,051 |
| Share-based compensation | 19,035 | 11,802 | 3,028 | 14,852 |
| Amortization of straight-line rent receivable (lessor) | 22,354 | 15,613 | 7,709 | 20,935 |
| Amortization of straight-line rent on operating leases (lessee) | 2,566 | 1,724 | 865 | 2,963 |
| Gain on sales of real estate properties and other assets | 99,678 | 22,907 | 2,904 | 77,670 |
| Loss on extinguishment of debt | -286 | - | - | - |
| Loss on derivatives | -2,844 | - | - | - |
| Impairment of real estate properties and credit loss reserves | 258,791 | 154,429 | 12,081 | 232,450 |
| Impairment of goodwill | 0 | 0 | 0 | 250,530 |
| Equity (income) loss from unconsolidated joint ventures | 446 | 159 | 1 | -360 |
| Distributions from unconsolidated joint ventures | 16,487 | 10,829 | 3,557 | 4,946 |
| Non-cash interest from financing and notes receivable | 657 | 395 | 178 | 1,610 |
| Other assets, including right-of-use-assets | 26,035 | 17,101 | 27,748 | 5,758 |
| Accounts payable and accrued liabilities | -32,993 | -31,051 | -64,848 | -27,925 |
| Other liabilities | -1,059 | 2,359 | 14,424 | -2,778 |
| Net cash provided by operating activities | 324,756 | 211,003 | 47,788 | 363,605 |
| Acquisitions of real estate | - | - | - | 0 |
| Development of real estate | 12,605 | 8,174 | 3,414 | 51,336 |
| Additional long-lived assets | 243,605 | 154,781 | 69,128 | 186,742 |
| Funding of mortgages and notes receivable | 6,027 | 2,799 | 0 | 3,565 |
| Investments in unconsolidated joint ventures | 1,546 | 978 | 852 | 0 |
| Proceeds from (investment in) financing receivable | - | 194 | 3 | - |
| Investment in financing receivable | 497 | - | - | 22 |
| Contributions from redeemable non-controlling interests | 0 | 0 | 0 | 13 |
| Proceeds from sales of real estate properties and additional long-lived assets | 393,111 | 69,805 | 19,353 | 722,940 |
| Proceeds from insurance recovery | 2,000 | 2,000 | - | - |
| Proceeds from notes receivable repayments | 53,513 | 53,190 | 15,211 | 861 |
| Net cash provided by investing activities | 184,344 | -41,931 | -38,833 | 482,149 |
| Borrowings on unsecured credit facility | 831,000 | 295,000 | 94,000 | 206,000 |
| Repayments on unsecured credit facility | 682,000 | - | - | - |
| Repayment on term loans | 108,532 | 35,140 | 35,000 | 250,000 |
| Repayments of notes and bonds payable | 251,042 | 250,692 | 345 | 25,130 |
| Dividends paid | 302,528 | 217,756 | 108,809 | 348,064 |
| Net proceeds from issuance of common stock | 0 | 0 | 0 | 104 |
| Common stock redemptions | 3,628 | 713 | 215 | 321 |
| Common stock repurchases | 0 | 0 | - | 423,070 |
| Distributions to non-controlling interest holders | 3,884 | 2,653 | 1,315 | 3,612 |
| Redemption of non-controlling interest | 677 | 330 | 330 | 625 |
| Debt issuance and assumption costs | 13,083 | 0 | - | 563 |
| Payments made on finance leases | 145 | 46 | 135 | 13 |
| Net cash used in financing activities | -534,519 | -212,330 | -52,149 | -845,294 |
| (decrease) increase in cash and cash equivalents | -25,419 | -43,258 | -43,194 | 460 |
| Cash and cash equivalents at beginning of period | - | - | 68,916 | - |
| Cash and cash equivalents at end of period | - | - | 25,722 | - |
Healthcare Realty Trust Inc (HR)
Healthcare Realty Trust Inc (HR)